<unk>  refers to a regimen consisting of rituximab, fludarabine and mitoxantrone used for the treatment of indolent non-Hodgkin's lymphoma.
FMR regimen
RCD regimen
IFL regimen
COPP regimen
FMC-R regimen
CAF regimen
FMC regimen
TC regimen